Towa Pharmaceutical Co., Ltd.
TWAPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $39 | $2,513 | $4,362 | $8,069 |
| Dep. & Amort. | $38 | $5,249 | $5,337 | $5,162 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$14 | -$1,647 | -$1,722 | -$18,395 |
| Other Non-Cash | -$8 | -$6,074 | $9,729 | $2,205 |
| Operating Cash Flow | $55 | $5,892 | $17,706 | -$2,959 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$61 | -$4,380 | -$6,827 | -$10,341 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$8 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$0 | $4,347 | -$587 | -$1,088 |
| Investing Cash Flow | -$69 | -$33 | -$7,414 | -$11,429 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$37 | $7,178 | -$3,108 | $7,279 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$1 | -$1,878 | -$61 | -$1,469 |
| Other Fin. Act. | $24 | -$5,257 | $9,154 | -$4,431 |
| Financing Cash Flow | -$13 | $43 | $5,985 | $1,379 |
| Forex Effect | -$5 | $13 | -$48 | $993 |
| Net Chg. in Cash | -$32 | $52,938 | -$29,231 | $29,231 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $367 | $0 | $29,231 | $0 |
| End Cash | $335 | $52,938 | $0 | $29,231 |
| Free Cash Flow | -$2 | $1,512 | $10,879 | -$13,300 |